MEI Pharma, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
MEI Pharma, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2024.
  • MEI Pharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2023 was $0.000.
  • MEI Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$11.9M, a 29570% decline from 2023.
  • MEI Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$40K, a 100% decline from 2022.
  • MEI Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $49.1M, a 1314% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.